Persistent Müllerian Duct Syndrome (PMDS)

Pediatric Surgery, AlSadik Hospital, Qatif, Saudi Arabia


10.1 Introduction

  • Persistent Müllerian duct syndrome (PMDS) is a rare disorder of sexual development.

  • It was first described by Nilson in 1939.

  • It is also called persistent oviduct syndrome.

  • It is considered by some to be a form of pseudohermaphroditism due to the presence of Müllerian derivatives.

  • This syndrome is characterized by the persistence of Mullerian duct derivatives (i.e. uterus, cervix, fallopian tubes and upper two thirds of vagina) in a phenotypically (normal male reproductive organs and normal male external genitalia) and karyotypically (46, XY) male patient.

  • Persistent Müllerian duct syndrome is usually caused by deficiency of fetal anti-Müllerian hormone (AMH) effect due to mutations of the gene for AMH or the anti-Müllerian hormone receptor, but may also be as a result of insensitivity to AMH of the target organ.

  • PMDS is caused by mutations in the AMH gene (PMDS type 1) or AMHR2 gene (PMDS type 2) and is inherited in an autosomal recessive manner.

  • It affects males who have normal chromosomes (46, XY) and have normal male reproductive organs and normal male external genitalia.

  • Persistent Müllerian duct syndrome affects only males and is inherited in an autosomal recessive pattern.

  • Affected males with this disorder have normal male reproductive organs. They also have internal female reproductive organs (a uterus and fallopian tubes).

  • The clinical features of PMDS depends on the mobility of the Müllerian derivatives (the uterus and fallopian tubes) which leads to either cryptorchidism or inguinal hernia. If the uterus and fallopian tube are mobile, they may descend into the inguinal canal during testicular descent. However, if the Müllerian derivatives are relatively immobile testicular descent may be impeded and the patient presents with undescended testes either unilateral or bilateral.

10.2 Embryology of Persistent Müllerian Duct Syndrome

  • The normal sexual differentiation depends on the genetic sex (XX or XY), which is established at the time of conception.

  • Following conception, the fetus is sexually indifferent with two different bipotential gonads and two pairs of internally developing Wolffian and Müllerian ducts.

  • These two undifferentiated bipotential gonads develop from the urogenital ridge and ultimately develop into either a testis or an ovary.

  • In addition to these bipotential gonads, fetuses of both sexes have also two sets of internal ducts: the Müllerian ducts and the Wolffian ducts which develop by 6–7 weeks of intra-uterine life.

  • Expression of sex-determining genes on the early bipotential gonad promotes development of the gonad into either a testis or an ovary.

  • Various genes expressed by the Y chromosome at very specific times during development are responsible for the differentiation of the testes.

  • In a male fetus, the testis differentiates by the end of the seventh gestational week.

  • A 35-kilobase (kb) gene determinant located on the distal short arm of the Y chromosome, known as the SRY (sex determining region of the Y chromosome) is responsible for initiating the indifferent gonads to develop into testes.

  • SRY codes for a transcription factor that acts in the somatic cells of the genital ridge.

  • Expression of this gene triggers a cascade of events that ultimately leads to the development of testicular Sertoli and Leydig cells.

  • SRY expression directs testicular morphogenesis, leading also to the production of MIS (Müllerian-inhibiting substance), and, later, testosterone.

  • Normal sex differentiation is controlled by:

    • Testosterone

    • Dihydrotestosterone

    • Müllerian Inhibiting Factor (MIF).

    • Sertoli cells secrete MIF, which leads to regression of the Müllerian ducts.

    • Leydig cells secret testosterone which has a direct effect on the Wolffian ducts, and promotes their differentiation into the epididymis, vas deferens, and seminal vesicles.

    • Testosterone and under the influence of 5-alpha reductase is converted to Dihydrotestosterone which induces male differentiation of external genitalia.

    • Patients with PMDS have both Wolffian and Müllerian duct structures due to a deficiency of MIF.

  • The external genitalia at 6–7 weeks gestation appear female and include a genital tubercle, the genital folds, urethral folds and a urogenital opening. These subsequently differentiate into male or female external genitalia under the influence of estrogen or dihydrotestosterone.

  • Male Differentiation:

    • The male sexual differentiation depends on two important steps:

      • The development of the bipotential gonad into a testis.

      • Internal and external genitalia differentiation.

    • The development of the bipotetial gonad into a testis occurs at about the sixth week of gestation under the influence of the SRY gene.

      • The SRY gene is located on the short arm of the Y-chromosome (Yp11.3). It is responsible for initiating sex differentiation by downstream regulation of sex-determining factors.

      • This involves expression of several genes including WT1, CBX2 (M33), SF1, GATA4/FOG2 is critical to SRY activation.

      • The SOX9 gene, located on 7q24.3-25.1, is essential for early testis development.

    • The second step in male sex differentiation involves internal and external genitalia differentiation.

    • The developed testes have two types of cells:

      • The Leydig cells

      • The Sertoli cells

    • The Sertoli cells produce the anti-Müllerian hormone (AMH).

    • The Leydig cells produce testosterone.

    • The AMH acts on its receptor in the Müllerian ducts and causes their regression.

    • Testosterone acts in a critical concentration-dependent and time-dependent manner to induce male sexual differentiation.

    • Testosterone acts on the androgen receptor in the Wolffian ducts to induce the formation of:

      • Epididymis

      • Ejaculatory ducts

      • Seminal vesicles.

    • The Leydig cells also produce insulin-like factor 3 (INSL3, relaxin-like factor), which play a role in the descent of testes to the scrotum.

    • Testesterone is also converted to dihydrotestosterone (DHT) under the influence of 5-alpha reductase enzyme, which acts on the androgen receptor of the prostate and external genitalia to cause its masculinization.

    • Binding of Testosterone and DHT to androgen receptors is necessary for androgen effect.

  • Female Differentiation:

Jul 10, 2017 | Posted by in UROLOGY | Comments Off on Persistent Müllerian Duct Syndrome (PMDS)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access